in past times couple of years, the UK has witnessed a revolution in clinical bodyweight‑loss remedies — in the introduction of semaglutide (Wegovy®) for the escalating attractiveness of tirzepatide (Mounjaro®). Now, A further identify is drawing focus in equally clinical and community well being